Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2022-02-01 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about an upcoming Board of Directors meeting scheduled for February 8, 2022, to consider and approve the unaudited financial results for the quarter ended December 31, 2021. It also mentions the closure of the trading window for insider trading compliance. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a notification about a future event (board meeting) and the trading window closure, not the actual financial report or earnings release. The document length is short (1546 characters), and it serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2022-02-01 English
We are enclosing herewith Certificate dated January 3, 2022 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for the period 01.12.2021 to 31.12.2021. It is addressed to stock exchanges and signed by the company secretary. The document is short (3269 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2022-01-20 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for the period 01.12.2021 to 31.12.2021. It is addressed to stock exchanges and signed by the company secretary. The document is short (3269 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2022-01-20 English
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015), we wish to inform you that the Board of Directors of the Company based on the recommendations ..
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to stock exchanges (BSE and NSE) regarding the appointment of Ms. Shilpa Shridhar Divekar as an Additional Director (Non-Executive & Independent) of the company. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in board composition. The content includes details about the appointment, term, profile, and affirmations related to the director's eligibility. There is no financial data, earnings information, or report attached or referenced as being published. The document is clearly about a change in the company's board of directors, fitting the category of Board/Management Information (MANG). The document length is 3710 characters, which is relatively short but contains substantive information about management changes, not just a brief notice or report publication announcement.
2021-12-30 English
Appointment
Board/Management Information Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (BSE and NSE) regarding the appointment of Ms. Shilpa Shridhar Divekar as an Additional Director (Non-Executive & Independent) of the company. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosure of events or information by listed entities. The content includes details about the appointment, term, profile, and affirmations related to the director's eligibility. There is no financial data, earnings information, or report attached or referenced as being published. The document is clearly about a change in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 3710 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2021-12-30 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about a specific event (loss of share certificates) and does not contain financial data, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital update. The document is a regulatory announcement related to compliance and disclosure requirements. Given the nature and length (1580 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.